EP 001 — Metabolic health · Health
Peptides & GLP-1s for Weight Loss — What You Need to Know About Longevity, Safety & Regulation
Jun 23, 2026 · 47:21
In Episode 1 of The Noor Effect, Dr. Furhan Qureshi sits down with triple board-certified hematologist and oncologist Dr. Rahul Singh for a wide-ranging conversation about peptides, GLP-1 medications, weight loss, longevity, and the rapidly evolving world of modern wellness. They discuss why peptides and GLP-1s have become so popular, the difference between FDA-approved medications and other peptide products, the importance of clinical research, and how consumers can evaluate the health information they encounter online. The conversation also explores obesity, metabolic health, body composition, and the growing role of GLP-1 medications in weight management.
In This Episode:
- What peptides are and how they differ from vitamins and hormones
- Why peptide therapy has become a major trend in wellness and longevity
- The difference between FDA-approved medications and other peptide products
- GLP-1 medications, including semaglutide and tirzepatide
- GLP-1s and their role in weight loss and metabolic health
- What clinical research and FDA regulation mean for emerging treatments
- The difference between weight loss and body composition
- Visceral fat, obesity, and metabolic health
- The risks of relying on social media and anecdotal health claims
- Why physician guidance and evidence-based information matter
About Dr. Rahul Singh:
Dr. Rahul Singh is a triple board-certified physician in Internal Medicine, Hematology, and Oncology, serving patients throughout the Northern Virginia region. A local resident with deep roots in the District of Columbia, Maryland, and Virginia area, Dr. Singh earned his bachelor's degree in Neurobiology and Physiology from the University of Maryland, College Park before receiving his medical degree from Ross University School of Medicine. He completed his Internal Medicine residency at New Hanover Regional Medical Center, an affiliate of the University of North Carolina at Chapel Hill, where he also served as Chief Resident in Quality Patient Safety. Driven by a passion for advancing cancer and blood disorder care, Dr. Singh completed his Hematology and Oncology fellowship at The George Washington University School of Medicine and Health Sciences. Dr. Singh is licensed in Virginia and is an active member of several professional organizations, including the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the American Medical Association (AMA). Outside of medicine, Dr. Singh enjoys spending time with his family, following sports, traveling, and exploring music.
Follow Dr. Q
Related articles
Transcript
Listen on